menu
    • menu

    Company profile for 9 Meters Biopharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    9 Meters Biopharma, Inc. (Nasdaq: NMTR) is a rare, orphan and unmet needs focused GI company. The Company is advancing drug candidates for short bowel syndrome and celiac disease. 9 Meters is led by a strong management team with a history of bringing novel therapeutics to market, and the Company owns all global rights to their products, which are backed by more than 150 patents worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    9 Meters BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8480 Honeycutt Road, Suite 120 Raleigh, NC 27615
    Telephone
    Telephone
    +1 (919) 275-1933
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://9meters.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/9meters/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/9metersbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Drug developer 9 Meters Biopharma files for bankruptcy protection
    Drug developer 9 Meters Biopharma files for bankruptcy protection

    18 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/drug-developer-9-meters-biopharma-files-bankruptcy-protection-2023-07-18/

    REUTERS
    18 Jul 2023
    Share Share
    9 Meters Biopharma Announces Management Change Vurolenatide
    9 Meters Biopharma Announces Management Change Vurolenatide

    30 May 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=758012&lang=en

    ACCESSWIRE
    30 May 2023
    Share Share
    9 Meters Biopharma Provides Business Update & Reports FYR for 1Q 2023
    9 Meters Biopharma Provides Business Update & Reports FYR for 1Q 2023

    15 May 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=755109&lang=en

    ACCESSWIRE
    15 May 2023
    Share Share
    9 Meters Announces Pre-IND Meeting with FDA Regarding NM-136 for Obesity
    9 Meters Announces Pre-IND Meeting with FDA Regarding NM-136 for Obesity

    05 Apr 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=747637&lang=en

    ACCESSWIRE
    05 Apr 2023
    Share Share
    9 Meters Reports Financial Results for Fourth Quarter and Full Year 2022
    9 Meters Reports Financial Results for Fourth Quarter and Full Year 2022

    28 Mar 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=746104&lang=en

    ACCESSWIRE
    28 Mar 2023
    Share Share
    9 Meters Biopharma Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    9 Meters Biopharma Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    15 Mar 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=743991&lang=en

    ACCESSWIRE
    15 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search